Wird geladen...
Pragmatic trial on inhaled corticosteroid withdrawal in patients with COPD in general practice
The therapeutic value of inhaled corticosteroids (ICSs) for COPD is limited. In published RCTs, ICS could be withdrawn in COPD patients without increasing exacerbation risk when bronchodilator treatment is optimized. Here we report on the feasibility and risks of ICS withdrawal in Dutch general prac...
Gespeichert in:
| Veröffentlicht in: | NPJ Prim Care Respir Med |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Nature Publishing Group UK
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7547069/ https://ncbi.nlm.nih.gov/pubmed/33037200 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41533-020-00198-5 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|